STOCK TITAN
  1. Home
  2. News
  3. ACCD

Accolade Inc - ACCD STOCK NEWS

Welcome to our dedicated news page for Accolade (Ticker: ACCD), a resource for investors and traders seeking the latest updates and insights on Accolade.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Accolade's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Accolade's position in the market.

News
Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024
Rhea-AI Summary
Accolade, Inc. (NASDAQ: ACCD) announced strong financial results for the fiscal fourth quarter and full year ended February 29, 2024, with revenue reaching $124.8 million for the quarter, a 26% increase from the previous year, and $414.3 million for the full year, a 14% increase. The company reported a net loss of $7.5 million for the quarter, a significant improvement from the $30.4 million loss in the prior year. Adjusted EBITDA surged to $18.5 million in the quarter, a 553% increase, while adjusted gross profit reached $67.7 million, a 35% increase. Accolade aims to achieve full-year profitability on an Adjusted EBITDA basis, with a revenue target of $480-$500 million for FY 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
-
News
Accolade to Announce Fiscal Fourth Quarter 2024 Financial Results
Rhea-AI Summary
Accolade, Inc. (ACCD) will release fiscal Q4 2024 financial results on April 25, 2024, followed by a conference call at 4:30 p.m. E.T. Pre-registration is required for telephone access, and an online webcast will be available. A replay will also be accessible.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.5%
Tags
earnings
-
News
Accolade Wins 2024 Artificial Intelligence Excellence Award
Rhea-AI Summary
Accolade, Inc. (ACCD) wins the Artificial Intelligence Excellence Award for its innovative use of AI technology in healthcare. The company's focus on Natural Language Processing and empathetic human approach sets it apart in improving healthcare experiences for its members.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.08%
Tags
none
News
Accolade Promotes Kelsi McDonald Harris to Chief People Officer
Rhea-AI Summary
Accolade, Inc. (ACCD) appoints Kelsi McDonald Harris as Chief People Officer and Senior Vice President to enhance employee experience and drive growth. McDonald Harris, with seven years at Accolade, will lead the People & Culture business unit overseeing talent acquisition, diversity, equity, and inclusion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.05%
Tags
none
-
News
Accolade To Present at Upcoming Investor Conferences
Rhea-AI Summary
Accolade, Inc. (ACCD) will be presenting at two investor conferences in March 2024, providing a webcast for both events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.78%
Tags
conferences
-
News
Accolade Welcomes Brightline to Trusted Partner Ecosystem
Rhea-AI Summary
Accolade, Inc. (Nasdaq: ACCD) partners with Brightline to enhance access to affordable pediatric behavioral health services, addressing the Physician Gap. The partnership aims to alleviate the burden on families, providing timely care for children and adolescents with mental health issues.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.65%
Tags
none
News
Accolade Welcomes Kindbody to Trusted Partner Ecosystem
Rhea-AI Summary
Accolade, Inc. partners with Kindbody to offer comprehensive fertility and family-building services to its customers and members. Kindbody's unique model provides affordable, integrated, and best-in-class care for infertility and family-forming journeys, addressing the fragmented and siloed nature of fertility services in the United States.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.33%
Tags
none
-
News
Accolade Announces Results for Fiscal Third Quarter 2024
Rhea-AI Summary
Accolade, Inc. (NASDAQ: ACCD) announced financial results for the fiscal third quarter ended November 30, 2023. The company reported a 9% increase in revenue, reaching $99.4 million, and a 47% decrease in net loss compared to the same period in 2022. Adjusted EBITDA improved by 55%, and adjusted gross profit increased by 10%. Accolade also provided forward-looking guidance for the fiscal year 2024, expecting a revenue range of $411 million to $415 million and Adjusted EBITDA between $(6) million and $(10) million. The company aims for a revenue growth of approximately 20% and an Adjusted EBITDA between 2% and 4% of revenue for the fiscal year ending February 28, 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
29%
Tags
earnings
-
News
Accolade To Present at Upcoming Investor Conferences
Rhea-AI Summary
Accolade, Inc. (NASDAQ: ACCD) to present at 42nd Annual J.P. Morgan Healthcare Conference and 26th Annual Needham Growth Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
conferences
News
Accolade to Announce Fiscal Third Quarter 2024 Financial Results
Rhea-AI Summary
Accolade, Inc. (NASDAQ: ACCD) will release fiscal third quarter 2024 financial results on January 8, 2024, after the market closes. A conference call to review results will be held at 4:30 p.m. E.T. on the same day. Details for listening via telephone and internet, as well as the replay, are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.39%
Tags
earnings
Stock ACCD logo
Accolade Inc

Nasdaq:ACCD

ACCD Rankings

#2677 Ranked by Market Cap
#4285 Ranked by Stock Gains
N/A Ranked by Dividends

ACCD Stock Data

650.22M
69.64M
2.99%
88.18%
4.14%
All Other Information Services
Information
Link
United States
Plymouth Meeting

About ACCD

accolade is a personalized health and benefits solution that dramatically improves the experience, outcomes and cost of healthcare for employers, health plans and their members. with a unique blend of compassionate advisors, clinical experts and intelligent technologies, we engage individuals and families in their health, establish trust, and influence their decisions at every stage of care. we’ve been recognized as one of the nation’s 25 most promising companies by forbes magazine, the fastest-growing private healthcare company by inc. 500, and a top workplace by multiple news publications. for more information, visit www.accolade.com.